low molecular weight heparin (enoxaparin sodium)
Sponsors
Tehran University of Medical Sciences, Shenzhen Zhongshan Urology Hospital, Medical University of Gdansk
Conditions
End Stage Renal Failure on DialysisHematologic MalignaciesInfertilityLeukemiaLymphomaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaPE - Pulmonary EmbolismVTE (Venous Thromboembolism)
Phase 4
Unknown Phase
Low Molecular Weight Heparin for Hemodialysis Anticoagulation
CompletedNCT01356615
Start: 2011-03-31End: 2011-03-31Updated: 2011-05-19
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
RecruitingNCT07270263
Start: 2024-11-22End: 2026-12-31Target: 100Updated: 2025-12-26